A 58-year-old with non-purulent cellulitis and systemic signs is started on IV cefazolin. He also has gout. For discharge, which step reduces CDI risk while maintaining efficacy if he develops CDI history later?APrefer fidaxomicin over vancomycin to treat future CDI recurrencesBAdd metronidazole to future CDI therapy routinelyCUse prolonged oral vancomycin taper for first CDIDUse bezlotoxumab adjunct in high-risk CDI recurrenceEAvoid future CDI treatment if symptoms mildCheck my answer